No Data
Earnings Preview: PLX to Report Financial Results Pre-market on November 14
$Protalix Biotherapeutics(PLX.US)$ is scheduled to release its financial results pre-market on November 14 ET. Earnings PreviewAnalysts estimate $Protalix Biotherapeutics(PLX.US)$ to post revenue of
Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024
Protalix BioTherapeutics To Present Data From Phase I Clinical Trial Of PRX-115 Recombinant PEGylated Uricase Product Candidate
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024
Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Protalix BioTherapeutics Announced That It Has Repaid In Full Its 7.50% Senior Secured Convertible Promissory Notes Financed Entirely With Available Cash
No Data
No Data